🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims at exploring the activity of a frontline approach based on ...
Status
Unknown
Location
U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno
Start Date
2017-05-31
Trial ID
NCT02744768
Treatments Being Tested
This is a single arm, open label, national multicenter clinical study inclu...
Status
Not Yet Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-06-15
Trial ID
NCT07003464
Treatments Being Tested
The AML18 Trial will evaluate several relevant therapeutic questions in Acu...
Status
Unknown
Location
Aalborg University Hospital
Start Date
2014-10-30
Trial ID
NCT02272478
Risk-stratified therapy based on molecular and cytogenetic for acute myeloi...
Status
Unknown
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Start Date
2018-08-10
Trial ID
NCT03620955
Treatments Being Tested
The detection of MRD is associated with an increased risk of relapse and ad...
Status
Recruiting
Location
Hospital Regional Alta Especialidad Bajio
Start Date
2024-10-15
Trial ID
NCT06291428
Treatments Being Tested
The purpose of this study is to test the safety of giving the patient speci...
Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital
Start Date
2013-05
Trial ID
NCT01860937
The purpose of this study is to find out whether Cord Blood Transplantation...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Start Date
2026-04-28
Trial ID
NCT07566377
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
Kent and Canterbury Hospital
Start Date
2006-12
Trial ID
NCT00458523
Treatments Being Tested
The investigator is testing the ability of a biologically active therapy in...
Status
Terminated
Location
Medical College of Wisconsin
Start Date
2021-01-01
Trial ID
NCT04556084
Treatments Being Tested
To improve outcomes for childhood cancer patients through the implementatio...
Status
Recruiting
Location
Women's and Children's Hospital
Start Date
2022-12-16
Trial ID
NCT05504772